Symbols / JNJ Stock $221.43 +0.05% Johnson & Johnson

Healthcare • Drug Manufacturers - General • United States • NYQ
JNJ (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Joaquin Duato
Exch · Country NYQ · United States
Market Cap 533.03B
Enterprise Value 565.97B
Income 21.04B
Sales 96.36B
FCF (ttm) 12.51B
Book/sh 33.73
Cash/sh 9.16
Employees 138,200
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 60.25%
P/E 25.63
Forward P/E 17.42
PEG 2.88
P/S 5.53
P/B 6.56
P/C —
EV/EBITDA 16.49
EV/Sales 5.87
Quick Ratio 0.69
Current Ratio 1.02
Debt/Eq 67.73
LT Debt/Eq —
EPS (ttm) 8.64
EPS next Y 12.71
EPS Growth -52.90%
Revenue Growth 9.90%
EPS Gr Q/Q -52.40%
Rev Gr Q/Q —
Earnings (next) 2026-07-15
Earnings (prior) 2026-04-14
ROA 8.42%
ROE 26.42%
ROIC —
Gross Margin 68.04%
Oper. Margin 27.41%
Profit Margin 21.83%
Shs Outstand 2.41B
Shs Float 2.40B
Insider Own 0.06%
Instit Own 75.85%
Short Float 0.91%
Short Ratio 2.59
Short Interest 19.67M
52W High 251.71
vs 52W High -12.03%
52W Low 146.12
vs 52W Low 51.54%
Beta 0.26
Impl. Vol. 0.78%
Rel Volume 0.45
Avg Volume 8.03M
Volume 3.63M
Target (mean) $252.42
Tgt Median $259.00
Tgt Low $155.00
Tgt High $285.00
# Analysts 24
Recom Buy
Prev Close $221.32
Price $221.43
Change 0.05%
About

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$252.42
Mean price target
2. Current target
$221.43
Latest analyst target
3. DCF / Fair value
$93.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$221.43
Low
$155.00
High
$285.00
Mean
$252.42

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-15 main Barclays Equal-Weight → Equal-Weight $255
2026-04-15 main Stifel Hold → Hold $250
2026-04-15 main Wells Fargo Overweight → Overweight $263
2026-04-10 main Morgan Stanley Overweight → Overweight $267
2026-03-30 reit RBC Capital Outperform → Outperform $255
2026-03-19 main Barclays Equal-Weight → Equal-Weight $234
2026-03-17 main HSBC Buy → Buy $280
2026-03-11 main Citigroup Buy → Buy $274
2026-03-05 main JP Morgan Neutral → Neutral $250
2026-02-03 main RBC Capital Outperform → Outperform $255
2026-01-28 up Morgan Stanley Equal-Weight → Overweight $262
2026-01-27 main Freedom Capital Markets Hold → Hold $220
2026-01-27 main Freedom Broker Hold → Hold $220
2026-01-23 main Guggenheim Buy → Buy $240
2026-01-22 main Citigroup Buy → Buy $250
2026-01-22 main B of A Securities Neutral → Neutral $221
2026-01-22 main TD Cowen Buy → Buy $250
2026-01-22 main Morgan Stanley Equal-Weight → Equal-Weight $200
2026-01-22 main Wells Fargo Overweight → Overweight $240
2026-01-22 main Scotiabank Sector Outperform → Sector Outperform $265
News
RSS: Latest JNJ news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-01 REED JOHN C Officer — 25,255 — —
2026-02-27 DECKER ROBERT J Officer — 4,075 $247.87 $1,010,070
2026-02-27 DECKER ROBERT J Officer — 4,075 $115.67 $471,355
2026-02-20 SCHMID TIMOTHY Officer — 1,322 $245.66 $324,763
2026-02-18 SCHMID TIMOTHY Officer — 22,623 $244.20 $5,527,506
2026-02-18 SCHMID TIMOTHY Officer — 29,554 $115.67 $2,741,335
2026-02-17 WOLK JOSEPH J Chief Financial Officer — 89,654 $242.68 $21,767,827
2026-02-17 WOLK JOSEPH J Chief Financial Officer — 107,784 $115.67 $8,193,223
2026-02-17 SWANSON JAMES D Chief Technology Officer — 62,080 $242.70 $15,109,759
2026-02-17 SWANSON JAMES D Chief Technology Officer — 73,140 $162.75 $10,202,710
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
94,193.00
+6.05%
88,821.00
+4.30%
85,159.00
+6.46%
79,990.00
Operating Revenue
94,193.00
+6.05%
88,821.00
+4.30%
85,159.00
+6.46%
79,990.00
Cost Of Revenue
30,256.00
+10.14%
27,471.00
+3.46%
26,553.00
+7.96%
24,596.00
Reconciled Cost Of Revenue
30,256.00
+10.14%
27,471.00
+3.46%
26,553.00
+7.96%
24,596.00
Gross Profit
63,937.00
+4.22%
61,350.00
+4.68%
58,606.00
+5.80%
55,394.00
Operating Expense
38,341.00
-4.39%
40,101.00
+9.57%
36,597.00
+6.45%
34,381.00
Research And Development
14,665.00
-14.90%
17,232.00
+14.23%
15,085.00
+6.72%
14,135.00
Selling General And Administration
23,676.00
+3.53%
22,869.00
+6.31%
21,512.00
+6.25%
20,246.00
General And Administrative Expense
—
22,869.00
+6.31%
21,512.00
+6.25%
20,246.00
Salaries And Wages
—
-900.00
+35.71%
-1,400.00
-16.67%
-1,200.00
Other Gand A
—
22,869.00
+6.31%
21,512.00
+6.25%
20,246.00
Total Expenses
68,597.00
+1.52%
67,572.00
+7.00%
63,150.00
+7.08%
58,977.00
Operating Income
25,596.00
+20.46%
21,249.00
-3.45%
22,009.00
+4.74%
21,013.00
EBITDA
41,055.00
+65.67%
24,781.00
+6.27%
23,320.00
-12.35%
26,605.00
Normalized EBITDA
35,164.00
+10.49%
31,826.00
+31.94%
24,122.00
-12.80%
27,663.00
Reconciled Depreciation
7,503.00
+2.23%
7,339.00
-1.96%
7,486.00
+7.40%
6,970.00
EBIT
33,552.00
+92.36%
17,442.00
+10.16%
15,834.00
-19.36%
19,635.00
Total Unusual Items
5,891.00
+183.62%
-7,045.00
-778.43%
-802.00
+24.20%
-1,058.00
Total Unusual Items Excluding Goodwill
5,891.00
+183.62%
-7,045.00
-778.43%
-802.00
+24.20%
-1,058.00
Special Income Charges
5,491.00
+181.41%
-6,745.00
-741.02%
-802.00
+24.20%
-1,058.00
Other Special Charges
-6,000.00
-209.09%
5,500.00
-24.66%
7,300.00
+180.77%
2,600.00
Impairment Of Capital Assets
81.00
-61.61%
211.00
-32.59%
313.00
-60.03%
783.00
Restructuring And Mergern Acquisition
428.00
-58.61%
1,034.00
+111.45%
489.00
+77.82%
275.00
Net Income
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Pretax Income
32,581.00
+95.25%
16,687.00
+10.79%
15,062.00
-22.20%
19,359.00
Net Non Operating Interest Income Expense
85.00
-85.27%
577.00
+18.00%
489.00
+128.50%
214.00
Interest Expense Non Operating
971.00
+28.61%
755.00
-2.20%
772.00
+179.71%
276.00
Net Interest Income
85.00
-85.27%
577.00
+18.00%
489.00
+128.50%
214.00
Interest Expense
971.00
+28.61%
755.00
-2.20%
772.00
+179.71%
276.00
Interest Income Non Operating
1,056.00
-20.72%
1,332.00
+5.63%
1,261.00
+157.35%
490.00
Interest Income
1,056.00
-20.72%
1,332.00
+5.63%
1,261.00
+157.35%
490.00
Other Income Expense
6,891.00
+233.94%
-5,145.00
+30.81%
-7,436.00
-298.07%
-1,868.00
Other Non Operating Income Expenses
1,000.00
-47.37%
1,900.00
+128.64%
-6,634.00
-719.01%
-810.00
Gain On Sale Of Security
400.00
+233.33%
-300.00
+50.00%
-600.00
+14.29%
-700.00
Tax Provision
5,777.00
+120.41%
2,621.00
+50.98%
1,736.00
-41.92%
2,989.00
Tax Rate For Calcs
0.00
+12.89%
0.00
+36.58%
0.00
-25.32%
0.00
Tax Effect Of Unusual Items
1,044.54
+194.40%
-1,106.55
-1099.77%
-92.23
+43.39%
-162.93
Net Income Including Noncontrolling Interests
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Net Income From Continuing Operation Net Minority Interest
26,804.00
+90.56%
14,066.00
+5.55%
13,326.00
-18.59%
16,370.00
Net Income From Continuing And Discontinued Operation
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Net Income Continuous Operations
26,804.00
+90.56%
14,066.00
+5.55%
13,326.00
-18.59%
16,370.00
Net Income Discontinuous Operations
0.00
0.00
-100.00%
21,827.00
+1289.37%
1,571.00
Normalized Income
21,957.54
+9.76%
20,004.45
+42.52%
14,035.77
-18.70%
17,265.07
Net Income Common Stockholders
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Diluted EPS
11.03
+90.50%
5.79
-57.80%
13.72
+103.86%
6.73
Basic EPS
11.13
+90.48%
5.84
-59.98%
14.60
+112.82%
6.86
Basic Average Shares
2,407.94
+0.04%
2,406.92
-0.01%
2,407.08
-7.90%
2,613.60
Diluted Average Shares
2,429.40
+0.00%
2,429.40
-5.12%
2,560.40
-3.89%
2,663.90
Diluted NI Availto Com Stockholders
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
199,210.00
+10.61%
180,104.00
+7.49%
167,558.00
-10.58%
187,378.00
Current Assets
55,624.00
-0.48%
55,893.00
+4.48%
53,495.00
-3.25%
55,294.00
Cash Cash Equivalents And Short Term Investments
20,102.00
-18.02%
24,522.00
+6.96%
22,927.00
+2.90%
22,281.00
Cash And Cash Equivalents
19,709.00
-18.24%
24,105.00
+10.27%
21,859.00
+69.59%
12,889.00
Cash Equivalents
16,410.00
-22.55%
21,187.00
+14.41%
18,519.00
+101.34%
9,198.00
Cash Financial
3,299.00
+13.06%
2,918.00
-12.63%
3,340.00
-9.51%
3,691.00
Other Short Term Investments
393.00
-5.76%
417.00
-60.96%
1,068.00
-88.63%
9,392.00
Receivables
21,331.00
+12.70%
18,927.00
-2.37%
19,387.00
+14.61%
16,915.00
Accounts Receivable
17,178.00
+15.74%
14,842.00
-0.21%
14,873.00
+5.94%
14,039.00
Gross Accounts Receivable
17,361.00
+15.67%
15,009.00
-0.20%
15,039.00
+5.85%
14,208.00
Allowance For Doubtful Accounts Receivable
-183.00
-9.58%
-167.00
-0.60%
-166.00
+1.78%
-169.00
Other Receivables
4,153.00
+1.66%
4,085.00
-9.50%
4,514.00
+56.95%
2,876.00
Inventory
14,191.00
+14.04%
12,444.00
+11.30%
11,181.00
+8.89%
10,268.00
Raw Materials
2,530.00
+8.26%
2,337.00
-0.76%
2,355.00
+37.00%
1,719.00
Work In Process
3,828.00
+35.99%
2,815.00
+44.21%
1,952.00
+23.78%
1,577.00
Finished Goods
7,833.00
+7.42%
7,292.00
+6.08%
6,874.00
-1.41%
6,972.00
Prepaid Assets
—
—
—
—
Assets Held For Sale Current
—
—
0.00
-100.00%
5,830.00
Other Current Assets
—
—
—
—
Total Non Current Assets
143,586.00
+15.60%
124,211.00
+8.90%
114,063.00
-13.64%
132,084.00
Net PPE
23,169.00
+12.92%
20,518.00
+3.12%
19,898.00
+10.66%
17,982.00
Gross PPE
54,364.00
+11.47%
48,768.00
+2.08%
47,776.00
+9.74%
43,534.00
Accumulated Depreciation
-31,195.00
-10.42%
-28,250.00
-1.33%
-27,878.00
-9.10%
-25,552.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
701.00
-2.37%
718.00
-9.69%
795.00
+1.40%
784.00
Buildings And Improvements
13,429.00
+9.03%
12,317.00
-0.47%
12,375.00
+7.89%
11,470.00
Machinery Furniture Equipment
32,873.00
+11.65%
29,444.00
+1.60%
28,979.00
+8.93%
26,603.00
Construction In Progress
7,361.00
+17.05%
6,289.00
+11.76%
5,627.00
+20.31%
4,677.00
Goodwill And Other Intangible Assets
99,175.00
+21.21%
81,818.00
+15.67%
70,733.00
-5.10%
74,536.00
Goodwill
48,772.00
+10.34%
44,200.00
+20.90%
36,558.00
+1.42%
36,047.00
Other Intangible Assets
50,403.00
+33.99%
37,618.00
+10.07%
34,175.00
-11.21%
38,489.00
Non Current Deferred Assets
6,874.00
-34.29%
10,461.00
+12.74%
9,279.00
+3.71%
8,947.00
Non Current Deferred Taxes Assets
6,874.00
-34.29%
10,461.00
+12.74%
9,279.00
+3.71%
8,947.00
Other Non Current Assets
14,368.00
+25.88%
11,414.00
-19.35%
14,153.00
-53.78%
30,619.00
Total Liabilities Net Minority Interest
117,666.00
+8.33%
108,614.00
+9.95%
98,784.00
-10.66%
110,574.00
Current Liabilities
54,126.00
+7.56%
50,321.00
+8.73%
46,282.00
-17.06%
55,802.00
Payables And Accrued Expenses
41,097.00
+2.20%
40,212.00
+3.54%
38,838.00
+6.68%
36,407.00
Payables
13,379.00
-5.00%
14,083.00
+11.55%
12,625.00
+4.26%
12,109.00
Accounts Payable
11,991.00
+16.29%
10,311.00
+7.05%
9,632.00
-2.60%
9,889.00
Current Accrued Expenses
27,718.00
+6.08%
26,129.00
-0.32%
26,213.00
+7.88%
24,298.00
Employee Benefits
6,957.00
-4.11%
7,255.00
+1.48%
7,149.00
+9.28%
6,542.00
Pensionand Other Post Retirement Benefit Plans Current
4,534.00
+9.89%
4,126.00
+3.33%
3,993.00
+30.96%
3,049.00
Total Tax Payable
1,388.00
-63.20%
3,772.00
+26.03%
2,993.00
+34.82%
2,220.00
Income Tax Payable
1,388.00
-63.20%
3,772.00
+26.03%
2,993.00
+34.82%
2,220.00
Current Debt And Capital Lease Obligation
8,495.00
+41.99%
5,983.00
+73.37%
3,451.00
-72.95%
12,756.00
Current Debt
8,495.00
+41.99%
5,983.00
+73.37%
3,451.00
-72.95%
12,756.00
Other Current Borrowings
8,495.00
+41.99%
5,983.00
—
—
Other Current Liabilities
—
—
—
3,590.00
Total Non Current Liabilities Net Minority Interest
63,540.00
+9.00%
58,293.00
+11.03%
52,502.00
-4.14%
54,772.00
Liabilities Heldfor Sale Non Current
—
—
0.00
-100.00%
2,901.00
Long Term Debt And Capital Lease Obligation
39,438.00
+28.67%
30,651.00
+18.43%
25,881.00
-3.74%
26,886.00
Long Term Debt
39,438.00
+28.67%
30,651.00
+18.43%
25,881.00
-3.74%
26,886.00
Tradeand Other Payables Non Current
486.00
+24.62%
390.00
-86.46%
2,881.00
-33.09%
4,306.00
Non Current Deferred Liabilities
6,791.00
+177.41%
2,448.00
-23.33%
3,193.00
-19.99%
3,991.00
Non Current Deferred Taxes Liabilities
6,791.00
+177.41%
2,448.00
-23.33%
3,193.00
-19.99%
3,991.00
Other Non Current Liabilities
9,868.00
-43.77%
17,549.00
+30.98%
13,398.00
+32.05%
10,146.00
Stockholders Equity
81,544.00
+14.06%
71,490.00
+3.95%
68,774.00
-10.46%
76,804.00
Common Stock Equity
81,544.00
+14.06%
71,490.00
+3.95%
68,774.00
-10.46%
76,804.00
Capital Stock
3,120.00
+0.00%
3,120.00
+0.00%
3,120.00
+0.00%
3,120.00
Common Stock
3,120.00
+0.00%
3,120.00
+0.00%
3,120.00
+0.00%
3,120.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
3,119.84
+0.00%
3,119.84
+0.00%
3,119.84
+0.00%
3,119.84
Ordinary Shares Number
2,407.94
+0.04%
2,406.92
-0.01%
2,407.08
-7.90%
2,613.60
Treasury Shares Number
711.90
-0.14%
712.92
+0.02%
712.76
+40.79%
506.25
Additional Paid In Capital
168,978.00
+8.46%
155,791.00
+1.27%
153,843.00
+19.87%
128,345.00
Retained Earnings
—
—
153,843.00
+19.87%
128,345.00
Gains Losses Not Affecting Retained Earnings
-14,930.00
-27.16%
-11,741.00
+6.27%
-12,527.00
+3.39%
-12,967.00
Treasury Stock
75,624.00
-0.07%
75,680.00
+0.02%
75,662.00
+81.47%
41,694.00
Other Equity Adjustments
-14,930.00
-27.16%
-11,741.00
+6.27%
-12,527.00
+3.39%
-12,967.00
Total Equity Gross Minority Interest
81,544.00
+14.06%
71,490.00
+3.95%
68,774.00
-10.46%
76,804.00
Total Capitalization
120,982.00
+18.45%
102,141.00
+7.91%
94,655.00
-8.71%
103,690.00
Working Capital
1,498.00
-73.12%
5,572.00
-22.75%
7,213.00
+1519.88%
-508.00
Invested Capital
129,477.00
+19.75%
108,124.00
+10.21%
98,106.00
-15.75%
116,446.00
Total Debt
47,933.00
+30.84%
36,634.00
+24.89%
29,332.00
-26.01%
39,642.00
Net Debt
28,224.00
+125.27%
12,529.00
+67.66%
7,473.00
-72.07%
26,753.00
Net Tangible Assets
-17,631.00
-70.71%
-10,328.00
-427.21%
-1,959.00
-186.38%
2,268.00
Tangible Book Value
-17,631.00
-70.71%
-10,328.00
-427.21%
-1,959.00
-186.38%
2,268.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
24,530.00
+1.09%
24,266.00
+6.47%
22,791.00
+7.54%
21,194.00
Cash Flow From Continuing Operating Activities
24,530.00
+1.09%
24,266.00
+6.47%
22,791.00
+7.54%
21,194.00
Net Income From Continuing Operations
26,804.00
+90.56%
14,066.00
-59.99%
35,153.00
+95.94%
17,941.00
Depreciation Amortization Depletion
7,503.00
+2.23%
7,339.00
-1.96%
7,486.00
+7.40%
6,970.00
Depreciation And Amortization
7,503.00
+2.23%
7,339.00
-1.96%
7,486.00
+7.40%
6,970.00
Other Non Cash Items
109.00
-94.08%
1,841.00
+281.16%
483.00
—
Stock Based Compensation
1,354.00
+15.14%
1,176.00
+1.20%
1,162.00
+2.11%
1,138.00
Provisionand Write Offof Assets
-1.00
-109.09%
11.00
0.00
+100.00%
-17.00
Asset Impairment Charge
204.00
-49.63%
405.00
-68.73%
1,295.00
+6.50%
1,216.00
Deferred Tax
1,538.00
+170.45%
-2,183.00
+47.95%
-4,194.00
-152.19%
-1,663.00
Deferred Income Tax
1,538.00
+170.45%
-2,183.00
+47.95%
-4,194.00
-152.19%
-1,663.00
Operating Gains Losses
-263.00
-16.37%
-226.00
+98.93%
-21,101.00
-5452.89%
-380.00
Change In Working Capital
-12,718.00
-792.32%
1,837.00
-26.73%
2,507.00
+162.50%
-4,011.00
Change In Receivables
-1,781.00
-338.67%
-406.00
+34.94%
-624.00
+51.63%
-1,290.00
Changes In Account Receivables
-1,781.00
-338.67%
-406.00
+34.94%
-624.00
+51.63%
-1,290.00
Change In Inventory
-1,450.00
-28.55%
-1,128.00
+14.74%
-1,323.00
+47.65%
-2,527.00
Change In Payables And Accrued Expense
2,377.00
+46.64%
1,621.00
-30.90%
2,346.00
+113.66%
1,098.00
Change In Other Current Assets
-6,167.00
-459.17%
1,717.00
+149.34%
-3,480.00
-606.55%
687.00
Change In Other Current Liabilities
-5,697.00
-17363.64%
33.00
-99.41%
5,588.00
+382.36%
-1,979.00
Investing Cash Flow
-23,588.00
-26.82%
-18,599.00
-2218.34%
878.00
+107.10%
-12,371.00
Cash Flow From Continuing Investing Activities
-23,588.00
-26.82%
-18,599.00
-2218.34%
878.00
+107.10%
-12,371.00
Net PPE Purchase And Sale
-4,832.00
-9.22%
-4,424.00
+2.62%
-4,543.00
-13.32%
-4,009.00
Purchase Of PPE
-4,832.00
-9.22%
-4,424.00
+2.62%
-4,543.00
-13.32%
-4,009.00
Capital Expenditure
-5,217.00
+15.95%
-6,207.00
-23.82%
-5,013.00
-25.04%
-4,009.00
Net Investment Purchase And Sale
741.00
+0.68%
736.00
-91.32%
8,484.00
-8.03%
9,225.00
Purchase Of Investment
-920.00
+46.70%
-1,726.00
+84.17%
-10,906.00
+66.32%
-32,384.00
Sale Of Investment
1,661.00
-32.53%
2,462.00
-87.30%
19,390.00
-53.40%
41,609.00
Net Business Purchase And Sale
-17,541.00
-15.81%
-15,146.00
0.00
+100.00%
-17,652.00
Purchase Of Business
-17,541.00
-15.81%
-15,146.00
0.00
+100.00%
-17,652.00
Gain Loss On Sale Of Business
-263.00
-16.37%
-226.00
+98.93%
-21,101.00
-5452.89%
-380.00
Net Intangibles Purchase And Sale
-385.00
+78.41%
-1,783.00
-279.36%
-470.00
0.00
Purchase Of Intangibles
-385.00
+78.41%
-1,783.00
-279.36%
-470.00
0.00
Net Other Investing Changes
-1,571.00
-177.85%
2,018.00
+177.82%
-2,593.00
-4089.23%
65.00
Financing Cash Flow
-5,539.00
-76.85%
-3,132.00
+80.21%
-15,825.00
-78.39%
-8,871.00
Cash Flow From Continuing Financing Activities
-5,539.00
-76.85%
-3,132.00
+80.21%
-15,825.00
-78.39%
-8,871.00
Net Issuance Payments Of Debt
9,637.00
-4.12%
10,051.00
+467.63%
-2,734.00
-136.69%
7,452.00
Issuance Of Debt
23,724.00
+8.15%
21,937.00
+0.67%
21,790.00
+35.04%
16,136.00
Repayment Of Debt
-14,087.00
-18.52%
-11,886.00
+51.53%
-24,524.00
-182.40%
-8,684.00
Long Term Debt Issuance
9,138.00
+37.21%
6,660.00
0.00
-100.00%
2.00
Long Term Debt Payments
-1,757.00
+27.49%
-2,423.00
-56.22%
-1,551.00
+27.32%
-2,134.00
Net Long Term Debt Issuance
7,381.00
+74.20%
4,237.00
+373.18%
-1,551.00
+27.25%
-2,132.00
Short Term Debt Issuance
14,586.00
-4.52%
15,277.00
-29.89%
21,790.00
+35.06%
16,134.00
Short Term Debt Payments
-12,330.00
-30.30%
-9,463.00
+58.81%
-22,973.00
-250.73%
-6,550.00
Net Short Term Debt Issuance
2,256.00
-61.20%
5,814.00
+591.46%
-1,183.00
-112.34%
9,584.00
Net Common Stock Issuance
-5,953.00
-144.78%
-2,432.00
-199.14%
-813.00
+86.53%
-6,035.00
Common Stock Payments
-5,953.00
-144.78%
-2,432.00
+51.88%
-5,054.00
+16.26%
-6,035.00
Common Stock Dividend Paid
-12,381.00
-4.72%
-11,823.00
-0.45%
-11,770.00
-0.75%
-11,682.00
Cash Dividends Paid
-12,381.00
-4.72%
-11,823.00
-0.45%
-11,770.00
-0.75%
-11,682.00
Repurchase Of Capital Stock
-5,953.00
-144.78%
-2,432.00
+51.88%
-5,054.00
+16.26%
-6,035.00
Proceeds From Stock Option Exercised
3,418.00
+307.88%
838.00
-23.40%
1,094.00
-17.68%
1,329.00
Net Other Financing Charges
-260.00
-211.11%
234.00
+114.61%
-1,602.00
-2564.62%
65.00
Changes In Cash
-4,597.00
-281.34%
2,535.00
-67.68%
7,844.00
+16441.67%
-48.00
Effect Of Exchange Rate Changes
201.00
+169.55%
-289.00
-158.04%
-112.00
+64.10%
-312.00
Beginning Cash Position
24,105.00
+10.27%
21,859.00
+54.73%
14,127.00
-2.48%
14,487.00
End Cash Position
19,709.00
-18.24%
24,105.00
+10.27%
21,859.00
+54.73%
14,127.00
Free Cash Flow
19,313.00
+6.94%
18,059.00
+1.58%
17,778.00
+3.45%
17,185.00
Interest Paid Supplemental Data
1,977.00
-0.65%
1,990.00
+8.39%
1,836.00
+86.97%
982.00
Income Tax Paid Supplemental Data
6,539.00
-2.61%
6,714.00
-21.69%
8,574.00
+64.16%
5,223.00
Common Stock Issuance
0.00
0.00
-100.00%
4,241.00
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
4,241.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category